Ratio Therapeutics, Inc.

Pharmaceutical company · Boston, Massachusetts, United States

Ratio Therapeutics, Inc. is a pharmaceutical company headquartered in Boston, Massachusetts, United States. Its earliest recorded incorporation is in 2021. It has reported private securities offerings to the US SEC, most recently $51 million sold in a notice filed in 2023.

Profile compiled from public records. Is this your company? Request a correction or update

Ratio Therapeutics at a glance

Typepharmaceutical company

HeadquartersBoston, Massachusetts, United States

Earliest incorporation on record2021

SEC CIK2004792

What does Ratio Therapeutics do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $50.7 million sold (2023).

Frequently asked questions about Ratio Therapeutics

Where is Ratio Therapeutics headquartered?

Ratio Therapeutics, Inc. is headquartered in Boston, Massachusetts, United States.

What does Ratio Therapeutics do?

Ratio Therapeutics, Inc. is a pharmaceutical company.

When was Ratio Therapeutics founded?

The earliest incorporation on record for Ratio Therapeutics, Inc. is in 2021, according to public company registers.

Similar companies

Transcode Therapeutics, Inc.Boston, Massachusetts, United States
Akouos, Inc.Boston, Massachusetts, United States
Astria Therapeutics, Inc.Boston, Massachusetts, United States
Albireo Pharma, Inc.Boston, Massachusetts, United States
Atea Pharmaceuticals, Inc.Boston, Massachusetts, United States
Rhythm Pharmaceuticals, Inc.Boston, Massachusetts, United States
Tango Therapeutics, Inc.Boston, Massachusetts, United States
Paratek Pharmaceuticals, Inc.Boston, Massachusetts, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences